C D Vizza - JoVE Visualize

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Critical Care (London, England)|December 12, 2001

Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertensionC D Vizza, G D Rocca, A D Roma, et al.

Heart (British Cardiac Society)|November 17, 2001

Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogueC D Vizza, S Sciomer, S Morelli, et al.

Minerva Anestesiologica|January 14, 2000

[Hemodynamic changes during continuous infusion with dobutamine in candidates for lung transplantation. Lung Transplantation Group]G Della Rocca, F Pierconti, C D Vizza, et al.

Heart (British Cardiac Society)|December 1, 2006

Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effectM D'Alto, C D Vizza, E Romeo, et al.

Regulatory Peptides|November 17, 2004

Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary diseaseC D Vizza, C Letizia, S Sciomer, et al.

Pulmonary Circulation|December 11, 2024

Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertensionP Vitulo, L Piccari, S J Wort, et al.

Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Critical Care (London, England)|December 12, 2001

Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertensionC D Vizza, G D Rocca, A D Roma, et al.

Heart (British Cardiac Society)|November 17, 2001

Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogueC D Vizza, S Sciomer, S Morelli, et al.

Minerva Anestesiologica|January 14, 2000

[Hemodynamic changes during continuous infusion with dobutamine in candidates for lung transplantation. Lung Transplantation Group]G Della Rocca, F Pierconti, C D Vizza, et al.

Heart (British Cardiac Society)|December 1, 2006

Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effectM D'Alto, C D Vizza, E Romeo, et al.

Regulatory Peptides|November 17, 2004

Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary diseaseC D Vizza, C Letizia, S Sciomer, et al.

Pulmonary Circulation|December 11, 2024

Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertensionP Vitulo, L Piccari, S J Wort, et al.

Pageof 3